Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MCRB – Seres Therapeutics, Inc.

Seres Therapeutics, Inc.
MCRB
$13.99
Name : Seres Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $122,957,552.00
EPSttm : -7.95
finviz dynamic chart for MCRB
Seres Therapeutics, Inc.
$13.99
1.89%
$0.27

Float Short %

13.37

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

1.62

EPS Last/This Y

-3.58

EPS This/Next Y

-1.43

Price

13.99

Target Price

13.33

Analyst Recom

2

Performance Q

47.26

Relative Volume

0.41

Beta

2.89

Ticker: MCRB




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04MCRB11.870.050.007302
2025-07-07MCRB10.910.050.007300
2025-07-08MCRB11.60.050.007301
2025-07-09MCRB12.190.050.147326
2025-07-10MCRB12.390.050.007537
2025-07-11MCRB12.540.051.317541
2025-07-14MCRB14.840.050.247564
2025-07-15MCRB14.580.060.398409
2025-07-16MCRB13.850.080.368914
2025-07-17MCRB14.070.090.158986
2025-07-18MCRB14.040.090.039114
2025-07-21MCRB13.840.090.246176
2025-07-22MCRB12.410.100.306252
2025-07-23MCRB13.120.110.406542
2025-07-24MCRB13.430.111.246916
2025-07-25MCRB14.370.121.357004
2025-07-28MCRB13.20.130.967107
2025-07-29MCRB12.190.151.277314
2025-07-30MCRB14.40.180.557607
2025-07-31MCRB14.140.180.037801
2025-08-01MCRB13.890.180.527911
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04MCRB11.8740.7- -3.58
2025-07-07MCRB10.9240.7- -3.58
2025-07-08MCRB11.6040.7- -3.58
2025-07-09MCRB12.3840.7- -3.58
2025-07-10MCRB12.3540.7- -3.58
2025-07-11MCRB12.5740.7- -3.58
2025-07-14MCRB14.8540.7- -3.58
2025-07-15MCRB14.6740.7- -3.58
2025-07-16MCRB13.9540.7- -3.58
2025-07-17MCRB14.0840.7- -3.58
2025-07-18MCRB14.1440.7- -3.58
2025-07-21MCRB13.8440.7- -3.58
2025-07-22MCRB12.4240.7- -3.58
2025-07-23MCRB13.0940.7- -3.58
2025-07-24MCRB13.4040.7- -3.58
2025-07-25MCRB14.5340.7- -3.58
2025-07-28MCRB13.2640.7- -3.58
2025-07-29MCRB12.1540.7- -3.58
2025-07-30MCRB14.4040.7- -3.58
2025-07-31MCRB14.2640.7- -3.58
2025-08-01MCRB13.9940.7- -3.58
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04MCRB-1.26-43.1910.55
2025-07-07MCRB-1.26-43.1910.55
2025-07-08MCRB-1.26-43.1910.55
2025-07-09MCRB-1.26-43.1910.55
2025-07-10MCRB-1.26-43.1910.55
2025-07-11MCRB-1.26-43.1910.76
2025-07-14MCRB-1.26-43.1910.76
2025-07-15MCRB-1.26-43.1910.76
2025-07-16MCRB-1.26-43.1910.76
2025-07-17MCRB-1.26-43.1910.76
2025-07-18MCRB-1.26-43.1910.76
2025-07-21MCRB-1.26-42.8010.76
2025-07-22MCRB-1.26-42.8010.76
2025-07-23MCRB-1.26-42.8010.76
2025-07-24MCRB-1.26-42.8010.76
2025-07-25MCRB-1.26-42.8013.37
2025-07-28MCRB-1.26-1.1513.37
2025-07-29MCRB-1.26-1.1513.37
2025-07-30MCRB-1.26-1.1513.37
2025-07-31MCRB-1.26-1.1513.37
2025-08-01MCRB-1.26-1.1513.37
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-2.24

Avg. EPS Est. Current Quarter

-2.61

Avg. EPS Est. Next Quarter

-0.62

Insider Transactions

-1.26

Institutional Transactions

-1.15

Beta

2.89

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

5

Fair Value

Quality Score

53

Growth Score

17

Sentiment Score

50

Actual DrawDown %

98.2

Max Drawdown 5-Year %

-99.1

Target Price

13.33

P/E

Forward P/E

PEG

P/S

P/B

2.42

P/Free Cash Flow

EPS

-9.99

Average EPS Est. Cur. Y​

-3.58

EPS Next Y. (Est.)

-5.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.41

Return on Equity vs Sector %

120.8

Return on Equity vs Industry %

139.5

EPS 1 7Days Diff

-3.7

EPS 1 30Days Diff

-2.46

EBIT Estimation

Seres Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 103
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline programs include SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease; and SER-287 and SER-301, which are in clinical trials for the treatment of mild-to-moderate ulcerative colitis. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today
news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance
stock history MCRB – Seres Therapeutics, Inc. invest stock market
stock prices MCRB premarket after hours
ticker MCRB fair value insiders trading